Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	45.35	-13.53	-24.77
Graham Fair Price	41.42	0.08	0.05
PEG	-53.02	< 0.005	0.02
Price/Book	9.37	1.21	1.11
Price/Cash Flow	81.78	-16.63	-91.23
Prices/Earnings	45.31	-0.94	-1.73
Price/Sales	-45.31	2.35	4.29
Price/FCF	81.78	-16.63	-91.23
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	3.03	0.16	0.15
Operating Margin	0.91	-0.51	-0.51
ROA	-100.00	-0.08	-0.04
ROE	-0.16	-0.32	-100.00
ROIC	-0.04	-0.08	-88.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.07	-0.05	49.18
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.81	-0.98	21.48
EPS QOQ	0.88	-1.02	16.42
FCF QOQ	0.92	-5.00	442.73
Revenue QOQ	-0.15	1.00	585.62
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	257.15	129.28	-49.72
Days Sales Outstanding (DSO)	13.66	57.77	322.99
Inventory Turnover	0.35	0.70	98.90
Debt/Capitalization	0.67	0.68	2.30
Quick Ratio	0.39	0.64	61.96
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.03	0.03	< 0.005
Cash	0.01	0.01	< 0.005
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	< 0.005	< 0.005	-500.15
Revenue	< 0.005	0.01	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.16	1.16	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-14.62	-7.99	45.37
Naive Interpretation	Member

06 - Financial Health · Bad

Rating